Prevalence and risk factors for drug resistance in patients with lower respiratory infections in Healthcare Associated Infection: a single centre study from Eastern India

Rao, C. Mohan; Subhankar, Saswat; Pradhan, Sujit; Dash, Debee Prasad.
Artículo | IMSEAR | ID: sea-194420

Documentos relacionados

  1. [Clostridium difficile Infection: Epidemiology, Clinical Presentation, Therapy and Prevention].
  2. [Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?]
  3. [Contact Investigation in Active Tuberculosis and Management of Latent TB Infection: 5-year Analysis at a German City Health Authority].
  4. Appropriateness of hospital admissions in a university hospital in Egypt: Analyzing a preintervention phase.
  5. [Non-severe Clostridioides difficile Infection: Are the data adequate to give up metronidazole?]
  6. [Interferon α therapy in patients with chronic hepatitis C infection: biopsychosocial consequences].
  7. [Herpes simplex virus infection: an overview of the problem, pharmacologic therapy and dietary measures].
  8. [Feline leukemia virus infection: importance and current situation in Switzerland].
  9. [Latent tuberculosis infection: prevalence amongst healthcare students at the Sapienza University of Rome (Italy)].
  10. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].